Selected article for: "lab workflow and RNA extraction"
Author: Crone, Michael A.; Priestman, Miles; Ciechonska, Marta; Jensen, Kirsten; Sharp, David J.; Anand, Arthi; Randell, Paul; Storch, Marko; Freemont, Paul S.
Title: A role for Biofoundries in rapid development and validation of automated SARS-CoV-2 clinical diagnostics
  • Cord-id: gkex3d2j
  • Document date: 2020_9_8
    • ID: gkex3d2j
    Snippet: The SARS-CoV-2 pandemic has shown how a rapid rise in demand for patient and community sample testing can quickly overwhelm testing capability globally. With most diagnostic infrastructure dependent on specialized instruments, their exclusive reagent supplies quickly become bottlenecks, creating an urgent need for approaches to boost testing capacity. We address this challenge by refocusing the London Biofoundry onto the development of alternative testing pipelines. Here, we present a reagent-ag
    Document: The SARS-CoV-2 pandemic has shown how a rapid rise in demand for patient and community sample testing can quickly overwhelm testing capability globally. With most diagnostic infrastructure dependent on specialized instruments, their exclusive reagent supplies quickly become bottlenecks, creating an urgent need for approaches to boost testing capacity. We address this challenge by refocusing the London Biofoundry onto the development of alternative testing pipelines. Here, we present a reagent-agnostic automated SARS-CoV-2 testing platform that can be quickly deployed and scaled. Using an in-house-generated, open-source, MS2-virus-like particle (VLP) SARS-CoV-2 standard, we validate RNA extraction and RT-qPCR workflows as well as two detection assays based on CRISPR-Cas13a and RT-loop-mediated isothermal amplification (RT-LAMP). In collaboration with an NHS diagnostic testing lab, we report the performance of the overall workflow and detection of SARS-CoV-2 in patient samples using RT-qPCR, CRISPR-Cas13a, and RT-LAMP. The validated RNA extraction and RT-qPCR platform has been installed in NHS diagnostic labs, increasing testing capacity by 1000 samples per day.

    Search related documents:
    Co phrase search for related documents
    • absence presence and absolute quantification: 1
    • absence presence and absorbance microplate reader: 1
    • absence presence and absorbance reader: 1
    • absence presence and acid sequence: 1, 2, 3, 4, 5, 6, 7, 8
    • absence presence and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • absolute concentration and acute respiratory syndrome: 1, 2
    • absolute quantification and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • absolute quantity and acute respiratory syndrome: 1
    • absorbance reader and acute respiratory syndrome: 1
    • accession number and acid sequence: 1, 2, 3, 4, 5, 6
    • accession number and acute respiratory syndrome: 1, 2, 3
    • acid extraction and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acid sequence and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25